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Abstract
GABAergic inhibition in the central nervous system (CNS) can occur via rapid, transient postsynaptic currents and via a tonic
increase in membrane conductance, mediated by synaptic and extrasynaptic GABAA receptors (GABAARs) respectively.
Retinal bipolar cells (BCs) exhibit a tonic current mediated by GABACRs in their axon terminal, in addition to synaptic
GABAAR and GABACR currents, which strongly regulate BC output. The tonic GABACR current in BC terminals (BCTs) is not
dependent on vesicular GABA release, but properties such as the alternative source of GABA and the identity of the
GABACRs remain unknown. Following a recent report that tonic GABA release from cerebellar glial cells is mediated by
Bestrophin 1 anion channels, we have investigated their role in non-vesicular GABA release in the retina. Using patch-clamp
recordings from BCTs in goldfish retinal slices, we find that the tonic GABACR current is not reduced by the anion channel
inhibitors NPPB or flufenamic acid but is reduced by DIDS, which decreases the tonic current without directly affecting
GABACRs. All three drugs also exhibit non-specific effects including inhibition of GABA transporters. GABACR r subunits can
form homomeric and heteromeric receptors that differ in their properties, but BC GABACRs are thought to be r1-r2
heteromers. To investigate whether GABACRs mediating tonic and synaptic currents may differ in their subunit composition,
as is the case for GABAARs, we have examined the effects of two antagonists that show partial r subunit selectivity:
picrotoxin and cyclothiazide. Tonic and synaptic GABACR currents were differentially affected by both drugs, suggesting
that a population of homomeric r1 receptors contributes to the tonic current. These results extend our understanding of
the multiple forms of GABAergic inhibition that exist in the CNS and contribute to visual signal processing in the retina.
Citation: Jones SM, Palmer MJ (2011) Pharmacological Analysis of the Activation and Receptor Properties of the Tonic GABACR Current in Retinal Bipolar Cell
Terminals. PLoS ONE 6(9): e24892. doi:10.1371/journal.pone.0024892
Editor: Steven Barnes, Dalhousie University, Canada
Received July 8, 2011; Accepted August 22, 2011; Published September 15, 2011
Copyright:  2011 Jones, Palmer. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by a Medical Research Council New Investigator Research Grant (ID 86420, www.mrc.ac.uk). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: m.j.palmer@cns.keele.ac.uk
Introduction
GABA, the major inhibitory neurotransmitter in the CNS, evokes
transient postsynaptic currents (IPSCs) via ionotropic GABAA
and GABAC receptors, as well as slower synaptic responses via
metabotropic GABAB receptors (GABARs). In addition, there is
increasingevidencethatGABAevokesatonicincreaseinmembrane
conductanceby activating extrasynaptic GABAreceptors,either asa
result of spill-over from synapses or via a non-synaptic mechanism
[1]. Tonic GABAR currents are mediated by GABAARs in brain
regions such as the hippocampus, cerebellum and thalamus, where
they have a role in controlling neuronal excitability and network
interactions [2,3]. In the retina, a GABACR-mediated tonic current
occursinthesynapticterminalsof bipolar cells (BCs),whichsimilarly
regulates membrane excitability [4,5]. Bipolar cell terminals (BCTs)
also exhibit rapid synaptic GABAAR and GABACRc u r r e n t st h a t
mediate feedback inhibition and limit BC glutamate release, thereby
modulating the light responses of ganglion cells, the output cells of
the retina [6].
We have found that the tonic GABACR current in BCTs, like
some tonic GABAAR currents [7–10], is not dependent on vesicular
GABA release [11]. The alternative source of GABA is currently
unknown but does not appear to involve reversal of GABA
transporters or release via hemichannels or P2X7 receptors [11]. It
was recently shown that the tonic release of GABA from cerebellar
glialcellscanoccurviaBestrophin1(Best1)Cl
-channels[12],which
have a significant permeability to large anions such as thiocyanate,
gluconate and glutamate [13,14]. In addition, volume-regulated
anion channels (VRACs) have been implicated in the non-vesicular
release of neurotransmitters [15]. Astrocytic or neuronal release via
anion channels may therefore be a potential source of GABA for
activating the tonic GABACR current in BCTs.
Tonic GABAAR currents are mediated by receptors that differ
in their subunit composition from synaptic GABAARs, conferring
distinct receptor properties that are suited to their localization and
function, such as high GABA sensitivity and reduced desensitiza-
tion [16,17]. GABACRs are composed of r subunits which are
highly expressed in the retina but are also localized to various
brain regions including the midbrain, thalamus, hippocampus
and cerebellum [18]. BC GABACRs are believed to be r1-r2
heteromers, although r subunits can also co-assemble with
GABAAR c subunits [19,20]. Heterologous expression of r1 and/
or r2 subunits reveals differences in receptor properties, for
example r1 homomers exhibit higher GABA sensitivity, lower
conductance and slower deactivation than r2 homomers, with
heteromeric r1-r2 receptors generally showing intermediate
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24892properties [21–24]. However, it is unknown whether receptor
subunit diversity contributes to the different forms of GABACR-
mediated inhibition in BCTs.
To further investigate the activation and receptor properties of
GABACRs mediating the tonic current in BCTs, we have
examined the effect of anion channel inhibitors and subunit-
selective antagonists on spontaneous and evoked GABACR
currents recorded directly from BCTs in goldfish retinal slices.
We find evidence for a role of DIDS-sensitive anion channels/
exchangers in tonic GABA release, and for a contribution of
homomeric r1 receptors to the tonic GABACR current.
Methods
Goldfish (Carassius auratus) were maintained in a 12 hour dark/
light cycle at 16uC. Prior to use, light-adapted goldfish were dark-
adapted for 1 hour to facilitate removal of the pigment epithelium.
Goldfish were killed by decapitation followed immediately by
destruction of the brain and spinal cord under Schedule 1 of the
UK Animals (Scientific Procedures) Act 1986. The experiments
were approved by Keele University’s Central Animal Facility
Management Committee. The eyeballs were removed and retinae
dissected out and treated for 25 minutes with hyaluronidase to
remove vitreous humor. Each retina was quartered, placed
ganglion cell layer down on filter paper and kept until needed at
4uC in medium comprising (mM): NaCl (127), KCl (2.5), MgCl2
(1.0), CaCl2 (0.5), Hepes (5), glucose (12), adjusted to pH 7.45 with
NaOH. Slices were cut at 250 mm intervals, transferred to the
recording chamber and perfused (1 ml.min
-1) with medium
comprising (mM): NaCl (108), KCl (2.5), MgCl2 (1.0), CaCl2
(2.5), NaHCO3 (24), glucose (12), gassed with 95% O2/5% CO2,
pH 7.4. For Ca
2+-free extracellular solution, CaCl2 was omitted
and MgCl2 was increased to 3.5 mM, to maintain the divalent
cation concentration. The osmolarities of the 2.5 mM Ca
2+ and
Ca
2+-free extracellular solutions were 267 mOsm and 269 mOsm
respectively. Slice preparation and recordings were performed at
room temperature (18–22uC), in daylight conditions.
Drugs were bath-applied via the extracellular solution and
locally-applied via pressure application from a low resistance glass
micropipette (,5 mm tip diameter) positioned 25-50 mm from the
recorded BCT using a Picospritzer II (Intracell, Royston, UK).
GABA and L-glutamate solutions for local application also
contained bicuculline (50 mM). L-glutamate-evoked GABA re-
sponses were evoked at intervals of at least 30 s in order to avoid
short-term depression of GABA release [25]. Salts and drugs,
including GABA, L-glutamate, 5-nitro-2-(3-phenylpropylamino)-
benzoic acid (NPPB), 2-(3-trifluoromethylphenylamino)-benzoic
acid (flufenamic acid), 4,49-diisothiocyanostilbene-2,29-disulphonic
acid (DIDS), picrotoxin, (1,2,5,6-tetrahydropyridin-4-yl)methyl-
phosphinic acid (TPMPA), bicuculline, 1,2,5,6-tetrahydro-1-2-
(diphenylmethylene)aminooxyethyl-3-pyridinecarboxylic acid hy-
drochloride (NO-711) and cyclothiazide were obtained from
Tocris (Bristol, UK), Sigma-Aldrich (Gillingham, UK) and Fisher
Scientific (Loughborough, UK).
Whole-cell voltage-clamp recordings were obtained from large
Mb-type BC terminals, as described previously [26]. Most
recordings were made from axon-severed terminals (determined
by their capacitive current) [26] to eliminate currents arising from
somatodendritic receptors and reduce the leak current. However,
no differences in GABAR currents were observed between axon-
severed terminals and the terminals of intact BCs. Patch pipettes
(5–8 MV) were pulled from borosilicate glass and filled with
solution comprising (mM): CsCl (115), Hepes (25), TEA-Cl (10),
Mg-ATP (3), Na-GTP (0.5), EGTA (0.5), pH 7.2, 270 mOsm.
CsCl-based intracellular solution was used to increase the driving
force through GABARs at a holding potential of 260 mV.
Membrane current (IM) was recorded via an EPC-10 patch-
clamp amplifier controlled by Patchmaster software (HEKA,
Lambrecht/Pfalz, Germany). Series resistance (RS) was monitored
and recordings were not used if IM changes were accompanied by
changes in RS. Off-line analysis was performed using IgorPro
software (WaveMetrics, Lake Oswego, OR). Pooled data are
expressed as mean 6 SEM; statistical significance was assessed
using paired or unpaired Student’s t tests as appropriate, with
P,0.05 considered significant.
Results
The role of anion channels: Effects of NPPB and
flufenamic acid
In order to investigate the role of Best1 and other anion channels
in non-vesicular GABA release in the retina, we tested the effect of
anion channel inhibitors on GABACR-mediated currents in BCTs.
Recordings were made with CsCl-based intracellular solution at a
holding potential of 260 mV, in the presence of bicuculline
(50 mM) to block GABAAR-mediated spontaneous IPSCs (sIPSCs).
The anion channel inhibitors were tested under both normal
(2.5 mM) Ca
2+ and Ca
2+-free extracellular conditions; when no
differences were observed between these conditions, the data has
been pooled.
Application of the anion channel inhibitor NPPB (50-100 mM)
to axon-severed BCTs initially evoked a small decrease, followed
by an increase, in the holding current over the course of about 20
minutes (2.5 mM Ca
2+ n=2, Ca
2+-free n=2; fig. 1A). Application
of flufenamic acid (FFA; 100–200 mM), either alone (2.5 mM Ca
2+
n=2) or in combination with NPPB (Ca
2+-free n=2), evoked the
same biphasic effect (fig. 1A). The potentiated current in NPPB
and/or FFA was subsequently inhibited by the addition of the
GABAR antagonist picrotoxin (200 mM; 2.5 mM Ca
2+ NPPB
n=1, FFA n=1; Ca
2+-free NPPB n=1, NPPB+FFA n=2;
fig. 1A), confirming that it was mediated by GABACRs. Responses
to locally-applied GABA (100 mM, 50–100 ms application) were
monitored in the same experiments to check for direct inhibition
of GABACRs by the anion channel blockers. The charge of
GABA-evoked responses was not reduced by NPPB (n=3), FFA
(n=1) or combined application (n=2). Instead, a significant
potentiation of GABA-evoked responses was observed, which
occurred in parallel with the tonic current increase (fig. 1B). The
GABA-evoked responses were subsequently fully blocked by
picrotoxin (n=4; fig. 1B).
The potentiating effects of NPPB and FFA on both the tonic
current and exogenous GABA responses may result from inhibition
of GABA uptake, as inhibition of GAT-1 by NO-711 (3 mM) exerts
a similar, though more pronounced, potentiating effect on the tonic
current [4] and on the charge of GABA-evoked responses (n=6;
fig. 1C). FFA and the related compound niflumic acid have
previously been found to inhibit certain GAT isoforms to variable
extents [27]. The small initial decrease in the holding current
may indicate a minor contribution of NPPB/FFA-sensitive anion
channels to non-vesicular GABA release, or may result from a non-
specific effect of these drugs on other ion channels (see below).
A markedly different effect of NPPB and FFA was observed in
recordings made from the terminals of intact BCs. Application of
NPPB (50 mM; n=3), FFA (100–200 mM; n=2) or both in
combination (n=2) resulted in a significant reduction in the holding
current (2.5 mM Ca
2+ n=3, Ca
2+-free n=4), which was subse-
quently further reduced by application of picrotoxin (200 mM;
fig.1D).Conversely,responsesevokedbylocalapplicationofGABA
Tonic GABACR Current in Bipolar Cell Terminals
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24892Tonic GABACR Current in Bipolar Cell Terminals
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24892(100 mM, 50–100 ms) were potentiated by NPPB and/or FFA in 4
out of 5 of these recordings (fig. 1E). The inhibitory effect of NPPB
and FFA on the holding current of intact BC recordings is most
likely due to the additional action of these drugs as hemichannel
inhibitors [28-31], as Mb-type BCs in goldfish retina are connected
via gap junctions in their dendrites [32]. The hemichannels appear
to account for a major part of the increased membrane conductance
of intact BCs compared with axon-severed BCTs [26].
The role of anion channels: Effects of DIDS
The anion channel/exchanger inhibitor DIDS, which has no
reported effect on hemichannels [28], reduces the tonic release of
glutamate in hippocampal slices [33]. The effect of DIDS on the
GABACR tonic current in BCTs was therefore investigated.
Application of DIDS (500 mM) to axon-severed BCTs in the
presence of bicuculline (50 mM) initially caused a significant
increase in the holding current (2.5 mM Ca
2+ n=9; Ca
2+-free
n=11; fig. 2A,B), that was accompanied by a large increase in the
amplitude and slowing of the decay of responses evoked by
exogenous GABA (100 mM, 50–100 ms; n=14; fig. 2C). In
addition, DIDS potentiated GABACR-mediated feedback currents
evoked by activation of amacrine cell reciprocal synapses by brief
BCT depolarization (to 210 mV for 5 ms; n=5; fig. 2D). A
similar, though larger, potentiation of synaptic feedback currents is
evoked by the GAT-1 inhibitor NO-711 (3 mM; n=6; fig. 2D) [4].
These effects are consistent with the reported action of DIDS as an
inhibitor of GAT-1 [34].
However, in the continuing presence of DIDS, the tonic current
gradually decreased. In 2.5 mM extracellular Ca
2+, the holding
current decreased from a peak of -187623 pA to -106622 pA
following 15–30 minutes of DIDS application (n=9), and was
further reduced to 21964 pA by subsequently addition of
picrotoxin (200 mM; n=7; fig. 2A). In Ca
2+-free extracellular
solution, the holding current decreased from a peak of
2101618 pA to -57612 pA following 15–30 minutes of DIDS
application (n=11), and was further reduced to -1963p Ab y
subsequently addition of picrotoxin (200 mM; n=8; fig. 2B).
During the period of tonic current reduction there was no
significant change in the charge or rate of decay of responses
evoked by exogenous GABA (2.5 mM Ca
2+ n=7, Ca
2+-free n=7;
fig. 2C), which were subsequently eliminated by picrotoxin
(200 mM; fig. 2C). These results strongly suggest that DIDS
reduces the tonic current without directly affecting BCT
GABACRs, and is therefore likely to be an inhibitor of the non-
vesicular GABA release mechanism.
To confirm that the effects of DIDS are mediated by changes in
the activation of GABACRs, and to investigate reported effects of
DIDS as an inhibitor of GABAARs [35], DIDS (500 mM) was
applied following inhibition of GABACRs with TPMPA (100–
200 mM), in 2.5 mM Ca
2+ extracellular solution without bicucul-
line. Under these conditions, GABAAR-mediated sIPSCs are
observed [5]. In the presence of TPMPA, DIDS had no effect on
the holding current, but did significantly reduce the frequency of
sIPSCs (fig. 3A). DIDS has previously been used in combination
with CsF as an intracellular inhibitor of GABAARs [36–38], based
on evidence that it blocks other types of Cl
- channel from either
side of the membrane [39,40]. To ascertain whether DIDS acts as
an intracellular blocker of GABAARs in BCTs, recordings were
made with DIDS (0.5–1 mM) included in the intracellular
solution. Intracellular DIDS had no effect on the amplitude of
sIPSCs but significantly reduced their frequency, compared with
control recordings (n=5 for DIDS and control, sIPSCs measured
during the 2
nd minute after gaining whole-cell access; fig. 3B).
Intracellular DIDS appeared to reduce the longevity of whole-cell
recordings (average duration 1063 minutes, n=5), but the
amplitude and frequency of sIPSCs did not change during the
course of recordings (2
nd minute compared with 6
th minute, n=5;
fig. 3B), and sIPSCs were still observed in the 20
th minute of the
longest duration recording (fig. 3B). DIDS therefore appears to act
as an intracellular inhibitor of GABAARs, but is more effective
when applied extracellularly.
GABACR subunit composition: Picrotoxin-sensitivity
To investigate whether the r subunit composition of GABACRs
mediating the tonic current differs from that of GABACRs
mediating the relatively fast synaptic currents in BCTs, we have
examined the effect of receptor antagonists that display some
subunit-selectivity. As above, GABACR currents were recorded at a
holding potential of 260 mV with CsCl-based intracellular solution
in the presence of the GABAAR antagonist bicuculline (50 mM).
The inhibition of GABACRs by picrotoxin is dependent on
subunit composition, with homomeric r1 receptors exhibiting
approximately 10-fold higher IC50 values than either r2 homo-
mers or r1- r2 heteromers in the presence of high GABA
concentrations [21–23,41]. The picrotoxin-sensitivity of tonic and
synaptic GABACR currents in BCTs was therefore examined.
Reciprocal amacrine cell synapses were activated by local
application of L-glutamate (glu; 100 mM, 10 ms), which evokes
large GABACR-mediated currents in BCTs [11]. The glu-evoked
responses were maximally-inhibited by 250 mM picrotoxin;
application of 400 mM picrotoxin had no further effect (n=3).
After obtaining baseline glu-evoked responses, picrotoxin was
applied at a concentration of 0.1, 0.5, 2, 10, 50 or 100 mM,
followed by a concentration of 250 mM (n=4–6 for each
concentration; fig. 4A). The charge of the GABACR-mediated
component of glu-evoked responses was normalized to the size of
the baseline GABACR response and plotted versus picrotoxin
concentration (fig. 4D). A fit of the dose-response plot with a Hill
equation gave an IC50 value of 1.4 mM.
To determine the picrotoxin-sensitivity of the tonic GABACR
current, it was first potentiated by application of NO-711 (3 mM)
[4]. NO-711 appears to exert its effects solely via inhibition of
Figure 1. The effect of NPPB and FFA on GABACR currents. A, Example experiments and mean data (2.5 mM Ca
2+ n=4, Ca
2+-free n=4)
showing the effects of NPPB (50–100 mM) and FFA (100–200 mM) on the holding current in recordings from axon-severed BCTs, with subsequent
addition of picrotoxin (PTX; 200 mM). NPPB/FFA(1) was measured 5–10 mins after drug application; NPPB/FFA(2) was measured 10–20 mins after
application. B, Example GABACR responses evoked by local application of GABA (100 mM, 100 ms) and the charge of GABA-evoked responses against
time for the recording in Ca
2+-free conditions in A, with mean data (2.5 mM Ca
2+ n=2, Ca
2+-free n=4) showing the effect of NPPB and/or FFA on the
charge of GABA-evoked responses. C, Example responses and mean data (n=6) showing the effect of the GAT-1 inhibitor NO-711 (3 mM) on GABA-
evoked responses (100 mM, 50–100 ms), and the associated increase in the tonic GABACR current. D, An example experiment in Ca
2+-free extracellular
solution and mean data (2.5 mM Ca
2+ n=3, Ca
2+-free n=4) showing the effect of NPPB (50 mM) and/or FFA (100–200 mM) on the holding current in
recordings from the terminals of intact BCs, with subsequent addition of picrotoxin (200 mM). E, Mean data showing the effect of NPPB (50 mM) and/
or FFA (100-200 mM) on the charge of GABA-evoked responses (2.5 mM Ca
2+ n=2, Ca
2+-free n=3) in recordings from the terminals of intact BCs. All
experiments in this and subsequent figures were performed with CsCl-based intracellular solution at a holding potential of -60 mV in the presence of
bicuculline (50 mM), unless stated otherwise. Example evoked currents show the average of 2–5 responses in each condition. Error bars represent
SEM; * denotes P,0.05.
doi:10.1371/journal.pone.0024892.g001
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GABACR-mediated mIPSCs [5] are not affected by application of
NO-711 (fig. 4C). Following the establishment of a stable baseline
tonic current in NO-711, picrotoxin was applied at a concentra-
tion of 0.5, 2, 10, 50, 100 or 200 mM, followed by a maximal
concentration of 250 mM (n=3-6 for each concentration; fig. 4B).
The amplitude of the GABACR-mediated tonic current was
normalized to the baseline current and plotted versus picrotoxin
concentration (fig. 4D). A fit of the dose-response plot with a Hill
equation gave an IC50 value of 8.5 mM. The amount of inhibition
of the tonic GABACR current was statistically different from that
of glu-evoked GABACR currents at picrotoxin concentrations
between 0.5 mM and 50 mM( P ,0.05). The approximately 6-fold
difference in picrotoxin sensitivity suggests that homomeric r1
receptors may contribute more to the tonic GABACR current than
to synaptic GABACR currents.
GABACR subunit composition: Cyclothiazide-sensitivity
Cyclothiazide has recently been shown to be a selective inhibitor
of r2 receptors, acting as a non-competitive antagonist with an
IC50 of ,12 mM. At a concentration of 300 mM, cyclothiazide
abolishes GABA responses mediated by r2 homomers but has
no significant effect on the responses of r1 homomers [42]. We
therefore examined the effect of cyclothiazide on GABACR-
mediated currents in BCTs. Bath-application of cyclothiazide
(300 mM), in the presence of bicuculline (50 mM), significantly
reduced the amplitude of the holding current (n=10), and also
reduced the spontaneous fluctuations of this current (fig. 5A).
Synaptic feedback currents evoked by brief BCT depolarization (to
210 mV for 5 ms) were initially potentiated during cyclothiazide
wash-on, as observed previously [43], due to the activity of
cyclothiazide as an inhibitor of AMPA receptor desensitization.
However, the feedback currents were subsequently virtually
eliminated (n=8; fig. 5B), although it is likely that run-down of
BCT exocytosis contributed to the feedback current reduction
[26]. GABACR currents evoked by local application of GABA
(100 mM, 50–100 ms) were also significantly reduced by cyclothia-
zide, but not completely eliminated (n=7; fig. 5C). GABA-evoked
responses had a slower rate of decay in the presence of
cyclothiazide than in control conditions (n=7; fig. 5C).
Figure 3. The effect of DIDS on GABAAR currents. A, An example recording and mean data (n=4) showing that application of DIDS (500 mM) in
the presence of TPMPA (200 mM) but not bicuculline has no effect on the holding current but inhibits spontaneous GABAAR-mediated IPSCs (sIPSCs).
B, Example current traces from recordings with and without DIDS (500 mM) included in the intracellular solution, with average sIPSCs from a different
recording with intracellular DIDS (500 mM), and mean sIPSC amplitude and frequency data in control recordings (n=5) and recordings with
intracellular DIDS (0.5–1 mM; n=5). Control(1) and DIDS(1) were measured during the 2
nd minute after gaining whole-cell access, DIDS(2) was
measured during the 6
th minute.
doi:10.1371/journal.pone.0024892.g003
Figure 2. The effect of DIDS on GABACR currents. A, Example experiment and mean data (n=9) showing the biphasic effect of DIDS (500 mM)
on the holding current in normal Ca
2+ extracellular solution, with subsequent application of picrotoxin (200 mM). DIDS(1) was measured at the peak
of the tonic current potentiation, DIDS(2) was measured following 15-30 mins of DIDS application, just prior to addition of picrotoxin. B, Example
experiment and mean data (n=11) showing a similar effect of DIDS (500 mM) in Ca
2+-free extracellular solution. C, The charge of GABA-evoked
responses (100 mM, 100 ms) against time and example responses for the experiment in A, with mean data (2.5 mM Ca
2+ n=7, Ca
2+-free n=7)
showing the effect of DIDS on the charge and the decay time-constant of GABA-evoked responses. D, Example responses and mean data showing
the effects of DIDS (500 mM; n=5) and NO-711 (3 mM; n=6) on the charge of GABACR-mediated synaptic feedback responses evoked by brief BCT
depolarization (to -10 mV for 5 ms).
doi:10.1371/journal.pone.0024892.g002
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tonic and GABA-evoked currents, NO-711 (3 mM) was applied in
the continuing presence of cyclothiazide. NO-711 increased the
holding current (n=10), which was subsequently inhibited by
application of picrotoxin (200–250 mM; fig. 5A). In addition, NO-
711 significantly increased the charge and slowed the decay of
responses evoked by exogenous GABA (n=7; fig. 5C). These
results support the view that the majority of BCT GABACRs are
r1-r2 heteromers, but provide evidence that a population of
homomeric r1 receptors contributes to the tonic current.
Discussion
The aim of the current experiments was to further our
understanding of two unknown properties of the tonic GABACR
current in BCTs: the non-vesicular source of GABA for activating
the current and the identity of the receptors mediating the current.
Following recent reports of non-vesicular GABA release via Best1
anionchannels[12],wetestedtheeffectsofanion channelinhibitors
on the tonic GABACR current. The results indicate that the GABA
release mechanism is insensitive to NPPB and FFA but sensitive to
DIDS. Allthreedrugsinhibitedto some extent theactivityofGABA
transporters, as evidenced by the potentiation of tonic, GABA-
evoked and synaptic feedback currents mediated by GABACRs. In
addition, NPPB and FFAexertedeffectson intactBCsviainhibition
of hemichannels, and DIDS was found to inhibit GABAAR-
mediated sIPSCs. However, there appeared to be no direct
inhibitory effect of NPPB, FFA or DIDS on GABACRs.
There is increasing evidence for the release of neurotransmitters,
in particular glutamate and ATP, from astrocytes [44,45]. GABA is
also known to be released from astrocytes in the hippocampus,
cerebellum, thalamus and olfactory bulb, with consequent activation
of neuronal GABAARs [12,46-48]. Astrocytes release ‘gliotransmit-
ters’ via several mechanisms including Ca
2+-dependent vesicular
exocytosis, reversal of transporters, and release via hemichannels,
ionotropic purinergic receptors and anion channels [49]. Various
different types of anion channel have been implicated in
gliotransmitter release including volume-regulated anion channels
(VRACs) [15] and more recently Ca
2+-activated anion channels
such as Best1, which are present in hippocampal and cerebellar
astrocytes, and which can mediate tonic GABA release [12,13].
Distinguishing pharmacologically between mechanisms of non-
vesicular release and between different types of Cl
- channel is
challenging due to the cross-reactivity of commonly-used anion
channel inhibitors with other release mechanisms, for example the
block of hemichannels by NPPB [50], and due to the lack of selectivity
of inhibitors between Cl
- channel classes [51]. However, the
insensitivity of the tonic GABACR current to carbenoxolone, PPADS
and Brilliant Blue G [11], and to NPPB and FFA indicates that
hemichannels, P2X7 receptors, VRACs and Best1 anion channels are
not major contributors to the non-vesicular GABA release that
activates this current. Reversal of GABA transporters also does not
seem to be involved [11]. The non-vesicular release of GABA in the
cerebellum that activates a tonic GABAAR current in granule cells was
similarly found to be independent of GABA transporter reversal and
VRACs, and to be potentiated rather than inhibited by NPPB [8].
Figure 4. Picrotoxin-sensitivity of GABACR currents. A, Example
GABACR responses evoked by local application of L-glutamate (glu;
100 mM, 10 ms) to activate reciprocal amacrine cell synapses, and their
inhibition by picrotoxin. Three individual responses (grey) and the mean
response (black) are shown for each condition. B, An example
experiment showing inhibition of the tonic GABACR current by the
same concentrations of picrotoxin, following potentiation of the current
by NO-711 (3 mM). C, Example average GABACR-mediated mIPSCs
during baseline and following application of NO-711 (3 mM), with mean
data for average mIPSC charge under these conditions (n=4). GABACR
mIPSCs were recorded in Ca
2+-free extracellular solution to facilitate
their detection, in the presence of bicuculline. D, Dose-response curves
for picrotoxin inhibition of glu-evoked (n=4–6) and tonic (n=3–6)
GABACR currents, fit with Hill equations to give IC50 values.
doi:10.1371/journal.pone.0024892.g004
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24892The tonic GABACR current in BCTs was significantly inhibited
by DIDS, but the identity of the DIDS-sensitive anion channel or
exchanger that mediates tonic GABA release in the retina is not
known. Interestingly, a similar NPPB-resistant but DIDS-sensitive
mechanism underlies the tonic release of glutamate in the
hippocampus [33]. One potential candidate is a type a large-
conductance Cl
- channel (maxi-Cl
-) that was identified in
drosophila and has three mammalian homologs that are activated
by either Ca
2+ or cell swelling, which is sensitive to DIDS but
resistant to niflumic acid [52]. In the current experiments, DIDS
failed to completely block the tonic GABACR current in BCTs,
even in Ca
2+-free extracellular solution, suggesting that either
DIDS at this concentration does not completely block the non-
vesicular release mechanism, or it blocks only one of two or more
contributing mechanisms. Alternatively, in the presence of DIDS
the release of GABA may be blocked but, due to the additional
action of DIDS as an inhibitor of GABA uptake, the ambient
extracellular GABA concentration remains sufficient to evoke
some tonic GABACR current.
The cellular source of GABA for activating the tonic GABACR
current in BCTs is also unknown, but the most likely sources are
amacrine cells and Mu ¨ller cells. BCTs are surrounded by amacrine
Figure 5. Cyclothiazide-sensitivity of GABACR-currents. A, Example experiment showing the effect of cyclothiazide (CTZ; 300 mM) on the
holding current, with subsequent application of NO-711 (3 mM) and picrotoxin (250 mM), with mean data for these experiments (n=10). B, Example
synaptic feedback currents evoked by brief BCT depolarization (to 210 mV for 5 ms) during wash-on of cyclothiazide, and mean data showing the
biphasic effect of cyclothiazide on the charge of feedback responses (n=8). CTZ(1) was measured 3–4 mins after application, CTZ(2) was measured 6–
8 mins after application. C, Example GABA-evoked responses (100 mM, 50–100 ms) showing the effects of cyclothiazide and NO-711 on response
amplitude (top) and kinetics (bottom, peak-scaled responses from a different experiment), with mean data (n=7) for the charge and decay time-
constant of GABA-evoked responses under these conditions.
doi:10.1371/journal.pone.0024892.g005
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mediate reciprocal and lateral feedback inhibition [53]. Although
non-vesicular neurotransmitter release is thought to occur primarily
from glial cells, DIDS-sensitive GABA-permeable anion channels
have been observed in Deiters neurons in the brainstem [54].
Mu ¨ller cells, the principle glial cells of the retina, are known to
release neuroactive substances such as ATP, with consequent effects
on synaptic activity and spiking in ganglion cells [55].
The tonic activation of membrane conductances as a result of
non-vesicular neurotransmitter release may be a general feature of
neuronal function in the CNS, involving not only inhibitory butalso
excitatory receptor systems. For example, the non-vesicular release
ofglutamatefromastrocytesevokesa tonicNMDA receptorcurrent
in hippocampal neurons [33,56–58]. A common feature of
GABAergic and glutamatergic tonic currents is their potentiation
by inhibition of neurotransmitter uptake, which may provide an
endogenous regulatory system for controlling the magnitude of the
current and its consequent effects on neuronal excitability [1].
BCs express both r1 and r2 GABACR subunits, which readily
form heteromeric receptors, and it is likely that most BC
GABACRs are r1-r2 heteromers [22,23,59-61]. However, the
additional expression of homomeric receptors would extend the
functional diversity of GABACR-mediated inhibition, as receptor
properties are dependent on r subunit composition. Each r
subunit has a similar structure to other members of the Cys-loop
superfamily of ligand-gated ion channels [62]. Amino-acid
substitutions in the pore-forming second transmembrane domain,
in particular a switch at the 29 position from proline in r1 to serine
in r2, underlies subunit differences in properties such as
deactivation rate, channel conductance and sensitivity to GABA
[24,63,64]. This amino-acid substitution also underlies the
difference in sensitivity to both picrotoxin and cyclothiazide of
r1 and r2 receptors [41,42].
We initially investigated the subunit composition of GABACRs in
BCTs by comparing the picrotoxin-sensitivity of glu-evoked and
tonic GABACR currents. Glu-evoked currents, designed to predom-
inantly activate synaptic GABACRs, were more sensitive to
picrotoxin than the tonic GABACR current, with IC50 values of
1.4 mMa n d8 . 5mM respectively. When expressed in heterologous
systems, perch r1A and r1B homomeric receptors have reported
IC50 values for picrotoxin inhibition of 10 mMa n d5 6 mM,
compared with 2 mMf o rr2A and r2B homomers [21,23].
Heteromeric r1B/r2A receptors exhibit a similar sensitivity to r2
homomers when the r subunits are expressed at a 1:1 ratio (IC50
value of 3 mM) [23]. A similar difference has been reported for
human r subunits (eg. IC50 values of 48 mMf o rr1a n d5mMf o rr2
homomeric receptors), with heteromeric receptors having an
intermediate sensitivity [22,41]. The subunit-specific differences in
picrotoxin sensitivity are most pronounced in the presence of
relatively high GABA concentrations (10–30 mM), due to a
competitive component in the inhibition of r1 receptors [41]. The
differenceinpicrotoxinsensitivityofthetonicandsynapticGABACR
currents in BCTs suggests that these currents may be mediated by
different (though probably overlapping) populations of GABACRs,
with a greater contribution of r1 receptors to the tonic current.
In addition we investigated the effect of cyclothiazide, which has
recently been shown to be a selective inhibitor of r2 subunits [42].
Cyclothiazide reduced the amplitude of the tonic current, inhibited
synaptic feedback currents and reduced the size of GABA-evoked
responses, consistent with most BCT GABACRs being r1-r2
heteromers. The reduction in the amplitude and spontaneous
fluctuations of the tonic current by cyclothiazide is similar to that
observed with application of Ca
2+-free solution [11], suggesting that
the summation of slow IPSCs evoked by spontaneous synaptic
release activating heteromeric GABACRs contributes to the tonic
current in BCTs [5]. Spontaneous GABA release occurs at a high
rate at amacrine cell to BCT synapses in retinal slices, as evidenced
by the high frequency of GABAAR-mediated sIPSCs observed in
theabsenceofbicuculline[11] (fig.3).Inthepresence ofbicuculline,
synaptic GABA release and the tonic GABACR current tend to be
potentiated due to amacrine cell disinhibition [6].
However,asmallconstanttoniccurrentremainedinthepresence
of 300 mM cyclothiazide that was potentiated by inhibition of
GABA uptake and is likely to be mediated by homomeric r1
receptors [42]. Small GABA-evoked currents were also observed in
the presence of cyclothiazide that were potentiated by NO-711 and
inhibited by picrotoxin. The slower decay rate of GABA-evoked
currents in cyclothiazide compared with control conditions is
consistent with reports of subunit-specific kinetics. For example, the
deactivation rate of homomeric r1 receptors is slower than for r1-
r2 heteromers, with respective time-constants of 14 s and 9 s for
human subunits, and 234 s and 75 s for perch subunits (B form)
[22,23]. The change in decay kinetics alsoprovides evidence against
an incomplete block of heteromeric GABACRs by cyclothiazide.
The lack of desensitization of BCT GABACRs [4] and the slow
deactivation of r1 subunits are both likely to contribute to the very
slow decay rateof GABA-evoked responses in the absenceof GABA
uptake (fig. 5). These properties, combined with a high affinity for
GABA [21,22], make homomeric r1 receptors particularly suitable
for mediating a tonic current in BCTs.
Given the lack of dependence on vesicular release of the tonic
GABACR current [11], it is likely that the population of
homomeric r1 receptors that contributes to this current is located
extrasynaptically. An analogous situation is found in central
neurons, where tonic GABAAR currents are mediated by
extrasynaptic receptors [16]. Fluorescence imaging of immunola-
beled r subunits in BCTs has shown ‘punctate’ labeling in several
species including goldfish, with labeling within the synaptic cleft at
the electron microscope level [65–68], reflecting the synaptic
localization of heteromeric receptors that mediate GABACR
feedback currents and spontaneous IPSCs. However, it has been
noted that rat BCTs also exhibit diffuse extrasynaptic r subunit
labeling [68], which may correspond with a population of
homomeric r1 receptors that contributes to the tonic current.
Identification of the subcellular localization of GABACR subunits
in BCTs, and mechanisms that target specific receptors to synaptic
or extrasynaptic sites, requires further investigation. In addition, it
will be interesting to determine whether synaptic and extrasynap-
tic GABACRs are differentially regulated, and the relative
importance of factors such as changes in receptor number or
properties, or in the rates of GABA release and uptake, in
modulating synaptic and tonic forms of GABACR-mediated
inhibition in BCTs.
In summary, these experiments indicate that tonic GABACR
currents in BCTs are activated by GABA released, in part, via a
DIDS-sensitive mechanism, and that homomeric r1r e c e p t o r s
contribute to this current. Tonic inhibition regulates the ability of
BCTs to fire Ca
2+-dependent action potentials [4], and is likely to
modulate the transmission of light responses to ganglion cells.
However, how this form of inhibition interacts with synaptic GABAAR
and GABACR-mediated inhibition, and with the multiple additional
forms of synaptic feedback that exist in BCTs, in the processing of
visual information in the retina remains to be determined.
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